MedTrace Logo

Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer

NCT02389673 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2015-03-17

No results posted yet for this study

Summary

Whether the patients with low grade ductal carcinoma in situ breast cancer should accept radiationtherapy is uncertain.Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation during surgery followed by external-beam radiation to the entire breast may kill more tumor cells.The clinical trial is conducting to find out the effectiveness of radiation therapy during surgery in treating women who have undergone breast-conversing surgery for low grade ductal carcinoma in situ breast cancer.

Conditions

  • Breast Neoplasms

Interventions

DEVICE

Intraoperative Radiotherapy

Boost with 20 Gy during BCS, EBRT with 46-50 Gy

Sponsors & Collaborators

  • Liao Ning

    lead OTHER

Principal Investigators

  • Liao Ning, MD,PhD · Guangdong Academy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2019-06-30
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389673 on ClinicalTrials.gov